Evercore Wealth Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-215,403
| Closed | -$45.3K | – | 435 |
|
|
2023
Q2 | $45.3K | Buy |
215,403
+72,265
| +50% | +$12.6K | ﹤0.01% | 410 |
|
|
2023
Q1 | $22.9K | Hold |
143,138
| – | – | ﹤0.01% | 402 |
|
|
2022
Q4 | $79.4K | Hold |
143,138
| – | – | ﹤0.01% | 390 |
|
|
2022
Q3 | $170K | Hold |
143,138
| – | – | ﹤0.01% | 368 |
|
|
2022
Q2 | $91K | Hold |
143,138
| – | – | ﹤0.01% | 384 |
|
|
2022
Q1 | $163K | Hold |
143,138
| – | – | ﹤0.01% | 423 |
|
|
2021
Q4 | $322K | Hold |
143,138
| – | – | 0.01% | 344 |
|
|
2021
Q3 | $490K | Hold |
143,138
| – | – | 0.01% | 290 |
|
|
2021
Q2 | $428K | Hold |
143,138
| – | – | 0.01% | 308 |
|
|
2021
Q1 | $462K | Hold |
143,138
| – | – | 0.01% | 303 |
|
|
2020
Q4 | $303K | Hold |
143,138
| – | – | 0.01% | 356 |
|
|
2020
Q3 | $167K | Hold |
143,138
| – | – | ﹤0.01% | 373 |
|
|
2020
Q2 | $129K | Hold |
143,138
| – | – | ﹤0.01% | 373 |
|
|
2020
Q1 | $120K | Hold |
143,138
| – | – | ﹤0.01% | 352 |
|
|
2019
Q4 | $137K | Hold |
143,138
| – | – | ﹤0.01% | 399 |
|
|
2019
Q3 | $147K | Hold |
143,138
| – | – | ﹤0.01% | 396 |
|
|
2019
Q2 | $258K | Buy |
143,138
+24,553
| +21% | +$39.5K | 0.01% | 359 |
|
|
2019
Q1 | $223K | Hold |
118,585
| – | – | 0.01% | 381 |
|
|
2018
Q4 | $140K | Hold |
118,585
| – | – | 0.01% | 365 |
|
|
2018
Q3 | $321K | Hold |
118,585
| – | – | 0.01% | 335 |
|
|
2018
Q2 | $226K | Hold |
118,585
| – | – | 0.01% | 371 |
|
|
2018
Q1 | $249K | Hold |
118,585
| – | – | 0.01% | 318 |
|
|
2017
Q4 | $241K | Hold |
118,585
| – | – | 0.01% | 334 |
|
|
2017
Q3 | $158K | Buy |
118,585
+11,494
| +11% | +$14.3K | 0.01% | 394 |
|
|
2017
Q2 | $168K | Hold |
107,091
| – | – | 0.01% | 388 |
|
|
2017
Q1 | $346K | Hold |
107,091
| – | – | 0.01% | 304 |
|
|
2016
Q4 | $145K | Hold |
107,091
| – | – | 0.01% | 431 |
|
|
2016
Q3 | $167K | Hold |
107,091
| – | – | 0.01% | 410 |
|
|
2016
Q2 | $142K | Buy |
107,091
+13,157
| +14% | +$61.5K | 0.01% | 416 |
|
|
2016
Q1 | $495K | Hold |
93,934
| – | – | 0.02% | 242 |
|
|
2015
Q4 | $737K | Buy |
93,934
+2,034
| +2% | +$17.5K | 0.03% | 211 |
|
|
2015
Q3 | $777K | Hold |
91,900
| – | – | 0.04% | 203 |
|
|
2015
Q2 | $1.01M | Hold |
91,900
| – | – | 0.05% | 198 |
|
|
2015
Q1 | $1.28M | Hold |
91,900
| – | – | 0.06% | 171 |
|
|
2014
Q4 | $1.55M | Buy |
91,900
+24,500
| +36% | +$357K | 0.08% | 139 |
|
|
2014
Q3 | $905K | Hold |
67,400
| – | – | 0.05% | 189 |
|
|
2014
Q2 | $859K | Hold |
67,400
| – | – | 0.04% | 201 |
|
|
2014
Q1 | $801K | Hold |
67,400
| – | – | 0.04% | 200 |
|
|
2013
Q4 | $931K | Hold |
67,400
| – | – | 0.05% | 200 |
|
|
2013
Q3 | $1.18M | Hold |
67,400
| – | – | 0.07% | 195 |
|
|
2013
Q2 | $1.09M | Buy |
+67,400
| New | +$2.09M | 0.06% | 204 |
|
Other funds holding INFI
Evercore Wealth Management's INFI Position: Q3 2023 in Review
Evercore Wealth Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 215,403 shares — an estimated $45.3K sold.
Evercore Wealth Management first reported a position in INFI in Q2 2013 and held it in 41 quarters. The position peaked at $1.55M in Q4 2014. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.
- Evercore Wealth Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Evercore Wealth Management sold 215,403 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $45.3K.
- Evercore Wealth Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 41 quarters.
- Evercore Wealth Management's Infinity Pharmaceuticals, Inc. position peaked at $1.55M in Q4 2014.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.
Based on Evercore Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.